Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry

被引:124
作者
Gaut, JP [1 ]
Byun, J
Tran, HD
Heinecke, JW
机构
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA
关键词
D O I
10.1006/abio.2001.5469
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Halogenation and nitration of biomolecules have been proposed as key mechanisms of host defense against bacteria, fungi, and viruses. Reactive oxidants also have the potential to damage host tissue, and they have been implicated in disease. In the current studies, we describe specific, sensitive, and quantitative methods for detecting three stable markers of oxidative damage: 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine. Our results indicate that electron capture-negative chemical ionization-gas chromatography/mass spectrometry (EC-NCI GC/MS) is 100-fold more sensitive than liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-MS/MS) for analyzing authentic 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine. Using an isotopomer of tyrosine to evaluate artifactual production of the analytes during sample preparation and analysis, we found that artifact generation was negligible with either technique. However, LC-MS/MS proved cumbersome for analyzing multiple samples because it required 1.5 h of run and equilibration time per analysis. In contrast, EC-NCI GC/MS required only 5 min of run time per analysis. Using EG-NCI GC/MS, we were able to detect and quantify attomole levels of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma. Our results indicate that EC-NCI GC/MS is a sensitive and specific method for quantifying free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in biological fluids in a single, rapid analysis and that it avoids generating any of the analytes ex vivo. (C) 2001 Elsevier Science.
引用
收藏
页码:252 / 259
页数:8
相关论文
共 27 条
[1]   Oxidative damage and tyrosine nitration from peroxynitrite [J].
Beckman, JS .
CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (05) :836-844
[2]   Isotope dilution mass spectrometric quantification of 3-nitrotyrosine in proteins and tissues is facilitated by reduction to 3-aminotyrosine [J].
Crowley, JR ;
Yarasheski, K ;
Leeuwenburgh, C ;
Turk, J ;
Heinecke, JW .
ANALYTICAL BIOCHEMISTRY, 1998, 259 (01) :127-135
[3]   MYELOPEROXIDASE, A CATALYST FOR LIPOPROTEIN OXIDATION, IS EXPRESSED IN HUMAN ATHEROSCLEROTIC LESIONS [J].
DAUGHERTY, A ;
DUNN, JL ;
RATERI, DL ;
HEINECKE, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :437-444
[4]   Formation of nitric oxide derived inflammatory oxidants by myeloperoxidase in neutrophils [J].
Eiserich, JP ;
Hristova, M ;
Cross, CE ;
Jones, AD ;
Freeman, BA ;
Halliwell, B ;
van der Vliet, A .
NATURE, 1998, 391 (6665) :393-397
[5]   Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts [J].
Frost, MT ;
Halliwell, B ;
Moore, KP .
BIOCHEMICAL JOURNAL, 2000, 345 :453-458
[6]  
HARRISON JE, 1976, J BIOL CHEM, V251, P1371
[7]   Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: A sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation [J].
Hazen, SL ;
Crowley, JR ;
Mueller, DM ;
Heinecke, JW .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 23 (06) :909-916
[8]   3-chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima [J].
Hazen, SL ;
Heinecke, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (09) :2075-2081
[9]  
Heinecke JW, 1999, METHOD ENZYMOL, V300, P124
[10]   Mass spectrometric quantification of amino acid oxidation products in proteins: insights into pathways that promote LDL oxidation in the human artery wall [J].
Heinecke, JW .
FASEB JOURNAL, 1999, 13 (10) :1113-1120